Gaudium IVF and Women Health Ltd
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
- Market Cap ₹ 725 Cr.
- Current Price ₹ 99.5
- High / Low ₹ 133 / 69.2
- Stock P/E 29.6
- Book Value ₹ 20.9
- Dividend Yield 0.00 %
- ROCE 29.3 %
- ROE 24.7 %
- Face Value ₹ 5.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 187 days.
- Working capital days have increased from 39.9 days to 90.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 37 | 44 | 48 | 71 | 104 | |
| 23 | 24 | 28 | 42 | 67 | |
| Operating Profit | 14 | 20 | 19 | 29 | 38 |
| OPM % | 37% | 46% | 41% | 41% | 36% |
| 0 | 0 | 0 | 0 | 1 | |
| Interest | 1 | 0 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 |
| Profit before tax | 12 | 18 | 17 | 25 | 32 |
| Tax % | 26% | 26% | 38% | 25% | 24% |
| 9 | 14 | 10 | 19 | 24 | |
| EPS in Rs | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 33% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 22% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 34% |
| Last Year: | 25% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| 6 | 12 | 17 | 21 | 25 | |
| 3 | 2 | 7 | 22 | 16 | |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| 4 | 18 | 19 | 18 | 30 | |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| 14 | 18 | 32 | 58 | 158 | |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -1 | 24 | 3 | 9 | 7 | |
| -1 | -16 | -5 | -15 | -88 | |
| 3 | 5 | -1 | 2 | 82 | |
| Net Cash Flow | 0 | 13 | -3 | -5 | 2 |
| Free Cash Flow | -2 | 9 | 1 | -0 | 5 |
| CFO/OP | 13% | 141% | 27% | 46% | 51% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | 76% | 45% | 49% | 29% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Jun - Gaudium IVF and Women Health Limited has informed about Schedule of meet
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29 May - Audio recording of FY26 audited results earnings call uploaded on company website on May 29, 2026.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 29 May
- Announcement under Regulation 30 (LODR)-Investor Presentation 29 May
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
29 May - Gaudium IVF reported FY26 revenue of ₹104.35 crore, PAT of ₹24.48 crore, and record Q4 results.
Concalls
-
May 2026TranscriptAI SummaryPPT
Business Profile[1][2]
The company operates in the Assisted Reproductive Technology (ART) and IVF segment in India, following a hub-and-spoke model across 30+ locations (7 hubs and 28 spokes). It also runs a 15-bed day-care hospital in Janakpuri (Delhi NCR) and operates an in-house pharmacy through its wholly owned subsidiary, Gaudium International Pvt. Ltd.